SARS-CoV-2 antibody immunoassays in serial samples reveal earlier seroconversion in acutely ill COVID-19 patients developing ARDS.

SARS-CoV-2 antibody immunoassays in serial samples reveal earlier seroconversion in acutely ill COVID-19 patients developing ARDS.

<h4>Objectives</h4>During the COVID-19 pandemic, SARS-CoV-2 antibody testing has been suggested for (1) screening populations for disease prevalence, (2) diagnostics, and (3) guiding therapeutic applications. Here, we conducted a detailed clinical evaluation of four Anti-SARS-CoV-2 immun...

Full description

Bibliographic Details
Main Authors: Marie-Luise Buchholtz, Florian M Arend, Peter Eichhorn, Michael Weigand, Alisa Kleinhempel, Kurt Häusler, Mathias Bruegel, Lesca M Holdt, Daniel Teupser
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0251587

Internet

https://doi.org/10.1371/journal.pone.0251587

Similar Items